Instrumentation Engineers (UK) - Industry Report 3/18/2013 \| published by: Plimsoll Publishing Ltd. ... NEWTON TECHNOLOGY GROUP PLC. This report covers activities such as gas, flow, load cells, valves, temperature and includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Instrumentation ... \| read more...	$525.00
Analytical Instrumentation & Systems (UK) - Industry Report 3/18/2013 \| published by: Plimsoll Publishing Ltd. ... WIKA INSTRUMENTS LTD and MARKES INTERNATIONAL LTD. This report covers activities such as control, systems, vacuum, surface analysis, x-span and includes a wealth of information on the financial trends over the past four years. Plimsoll ... \| read more...	$525.00
Medical & Scientific Research (European) - Industry Report 3/18/2013 \| published by: Plimsoll Publishing Ltd. ... & DEVELOPPEMENT, NEDERLANDSE ORGANISATIE VOOR TOEGEPAST-NATUURWETENSCHAPPELIJK ONDERZOEK TNO and CBMM EUROPE B.V.. This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Medical & Scientific Research ... \| read more...	$1,200.00
Proteomics (Global) - Industry Report 3/18/2013 \| published by: Plimsoll Publishing Ltd. ... This report includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Proteomics (Global) analysis is ideal for anyone wanting to: See the market leaders Identify companies heading ... \| read more...	$1,425.00
Bioscience (UK) - Industry Report 3/18/2013 \| published by: Plimsoll Publishing Ltd. ... LTD. This report covers activities such as research, science, pharmaceutical, antibodies, biologics and includes a wealth of information on the financial trends over the past four years. Plimsoll Publishing’s latest Bioscience analysis is ideal for ... \| read more...	$525.00
Biotechnology Products Markets in China 3/15/2013 \| published by: Asia Market Information & Development Company ... investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2002, 2007 and 2012) and long-term forecasts through 2017 and 2022 are presented. Major producers in ... \| read more...	$2,000.00
Imaging in Cancer Drug Development 3/13/2013 \| published by: SMI Publishing, Ltd ... modalities, drug development and clinical development alongside networking with key industry professionals. This leading event will provide attendees with a complete view of the field and will focus primarily on oncology imaging modalities and applications ... \| read more...	$788.78
Global Life Science and Chemical Instrumentation Market 2012-2016 3/12/2013 \| published by: Infiniti Research Limited ... rapid technological developments in the Diagnostics industry. The Global Life Science and Chemical Instrumentation market has also been witnessing an increasing number of outsourcing activities. However, the intense competition among vendors could pose a challenge ... \| read more...	$2,500.00
Cell Therapeutics, Inc. (CTIC) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... lymphoma (NHL); Tosedostat, is in Phase II clinical trial for the treatment of acute myeloid leukemia (AML) and myelodysplasia (MDS); Brostallicin, being studied for the treatment of triple-negative metastatic breast cancer in Phase II and ... \| read more...	$125.00
Enzo Biochem, Inc. (ENZ) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... development, manufacture, licensing and commercializating of innovative health care products, platforms and services based on molecular and cellular technologies. Enzo Biochem, Inc. Key Recent Developments Nov 02, 2012: Enzo Awarded $49m In Trial Against Applera ... \| read more...	$125.00
Advanced Proteome Therapeutics Corporation (APC) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... proprietary human protein pharmaceuticals with enhanced therapeutic properties by using protein modification technologies applied in cancer therapeutics. APC through its research and development activity applies leading edge chemical and biochemical methodologies to commercially viable proteins. ... \| read more...	$125.00
Living Cell Technologies Limited (LCT) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... treatment of Diabetes, Parkinson's disease, Huntington's disease, stroke and hearing loss, which are in various stages of development from preclinical to pivotal trials. The company's lead product, Diabecell is developed to normalize blood glucose levels ... \| read more...	$125.00
Sartorius Stedim Biotech S.A. (DIM) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... into validation services, process analysis, training, process optimization, instrument services, spare parts and consumables and information on disposal. The company's product portfolio comprises various types of filters, analyzers, process control tools, UV-C inactivation systems, bioreactors, ... \| read more...	$125.00
Global Nanotechnology Drug Delivery Market 2012-2016 3/12/2013 \| published by: Infiniti Research Limited ... cost. The Global Nanotechnology Drug Delivery market has also been witnessing an increase in customer support services. However, the increasing safety concerns could pose a challenge to the growth of this market. TechNavio's report, Global ... \| read more...	$2,000.00
Generex Biotechnology Corporation (GNBT) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... virus, melanoma, ovarian cancer, HIV, HPV, allergy and Type I diabetes mellitus. It has a proprietary platform technology to deliver drugs into the human body through the oral cavity. The proprietary and proven advanced technology ... \| read more...	$125.00
Genzyme Corporation - Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... diseases, orthopedics, organ transplant, cancer, and immune disease. The company is also developing products on cardiovascular diseases, neurodegenerative diseases and other areas. It operates through two business units, namely, Rare Diseases division and Multiple Sclerosis ... \| read more...	$125.00
Global Laboratory Analytical Instrument Market 2012-2016 3/12/2013 \| published by: Infiniti Research Limited ... of large molecule analysis instruments by pharmaceutical companies. The Global Laboratory Analytical Instrument market has also been witnessing the development of instruments with increased features and functionalities. However, the long replacement cycles of laboratory analytical ... \| read more...	$3,000.00
Biotron Limited (BIT) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... research and development programs are used in treatment of hepatitis C virus (HCV), human immunodeficiency virus (HIV), Dengue virus and Influenza virus. Its offers a wide portfolio of clinical and preclinical antiviral programs that include ... \| read more...	$125.00
Myriad Genetics, Inc. (MYGN) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... predictive medicine, prognostic medicine and personalized medicine products in the areas of oncology and CNS related disorders. Myriad Genetics, Inc. Key Recent Developments Feb 05, 2013: Myriad Genetics Reports Revenue Of $149.1m In Q2 Fiscal ... \| read more...	$125.00
Agenix Limited (AGX) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... ThromboView and AGX-1009. ThromboView is a novel radio-labelled monoclonal antibody imaging agent being developed to diagnose patients suffering from acute pulmonary embolism. AGX-1009 is a reverse transcriptase inhibitor (NtRTI) prodrug of tenofovir. The company operates ... \| read more...	$125.00
Narhex Life Sciences Limited (NLS) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... inhibitor DG17. DG17 is the water-soluble prodrug of the active anti-HIV drug DG35. NLS targets to develop DG17 for regulatory approval in OECD countries such as European Union, USA, Canada, Japan and Australia/New Zealand. It ... \| read more...	$125.00
Palatin Technologies, Inc. (PTN) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... programs targeting melanocortin and natriuretic receptors, including products to treat congestive heart failure, obesity, metabolic syndrome and sexual dysfunction. The company’s primary product in the clinical development stage is bremelanotide, which is to treat female ... \| read more...	$125.00
Genetic Technologies Limited (GTG) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... testing including cancer diagnostics, licensing, and research. The company offers genetic testing services for genetic testing of human, animal and plants. It offers genetic testing for parentage, disease susceptibility, individual identity, forensics and sports performance ... \| read more...	$125.00
ImClone LLC - Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... development targeting a variety of cancers. The company has several investigational monoclonal antibodies in various stages of clinical development. It has built a novel pipeline of product candidates to address specific genetic mechanisms involved in ... \| read more...	$125.00
Imugene Limited (IMU) - Financial and Strategic SWOT Analysis Review 3/12/2013 \| published by: GlobalData ... proprietary drug delivery technology, enables the active ingredient of drugs to be absorbed straight into the bloodstream when placed inside the cheek or under the tongue. Imugene focuses on the development of five priority targets, ... \| read more...	$125.00

< prev 5 6 7 8 9 10 11 12 13 14 next >